Literature DB >> 19752037

Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections.

Timothy S C Hinks1, Davinder P S Dosanjh, John A Innes, Geoffrey Pasvol, Sarah Hackforth, Hansa Varia, Kerry A Millington, Xiao-Qing Liu, Mustafa Bakir, Ahmet Soysal, Robert N Davidson, Rubamalar Gunatheesan, Ajit Lalvani.   

Abstract

The majority of individuals infected with Mycobacterium tuberculosis achieve lifelong immune containment of the bacillus. What constitutes this effective host immune response is poorly understood. We compared the frequencies of gamma interferon (IFN-gamma)-secreting T cells specific for five region of difference 1 (RD1)-encoded antigens and one DosR-encoded antigen in 205 individuals either with active disease (n = 167), whose immune responses had failed to contain the bacillus, or with remotely acquired latent infection (n = 38), who had successfully achieved immune control, and a further 149 individuals with recently acquired asymptomatic infection. When subjects with an IFN-gamma enzyme-linked immunospot (ELISpot) assay response to one or more RD1-encoded antigens were analyzed, T cells from subjects with active disease recognized more pools of peptides from these antigens than T cells from subjects with nonrecent latent infection (P = 0.002). The T-cell frequencies for peptide pools were greater for subjects with active infection than for subjects with nonrecent latent infection for summed RD1 peptide pools (P <or= 0.006) and culture filtrate protein 10 (CFP-10) antigen (P = 0.029). Individuals with recently acquired (<6 months) versus remotely acquired (>6 months) latent infection did not differ in numbers of peptide pools recognized, proportions recognizing any individual antigen or peptide pool, or antigen-specific T-cell frequencies (P >or= 0.11). The hierarchy of immunodominance for different antigens was purified protein derivative (PPD) > CFP-10 > early secretory antigenic target 6 > Rv3879c > Rv3878 > Rv3873 > Acr1, and the hierarchies were very similar for active and remotely acquired latent infections. Responses to the DosR antigen alpha-crystallin were not associated with latency (P = 0.373). In contrast to the RD1-specific responses, the responses to PPD were not associated with clinical status (P > 0.17) but were strongly associated with positive tuberculin skin test results (>or=15-mm induration; P <or= 0.01). Our results suggest that RD1-specific IFN-gamma-secreting T-cell frequencies correlate with the presence of disease rather than with protective immunity in M. tuberculosis-infected individuals and do not distinguish recently acquired asymptomatic infection from remotely acquired latent infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752037      PMCID: PMC2786487          DOI: 10.1128/IAI.01436-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Authors:  Katie Ewer; Jonathan Deeks; Lydia Alvarez; Gerry Bryant; Sue Waller; Peter Andersen; Philip Monk; Ajit Lalvani
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

2.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence.

Authors:  Philip S Renshaw; Parthena Panagiotidou; Adam Whelan; Stephen V Gordon; R Glyn Hewinson; Richard A Williamson; Mark D Carr
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

4.  Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection.

Authors:  Xiao-Qing Liu; Davinder Dosanjh; Hansa Varia; Katie Ewer; Paul Cockle; Geoffrey Pasvol; Ajit Lalvani
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.

Authors:  Priscille Brodin; Laleh Majlessi; Roland Brosch; Debbie Smith; Gregory Bancroft; Simon Clark; Ann Williams; Claude Leclerc; Stewart T Cole
Journal:  J Infect Dis       Date:  2004-06-04       Impact factor: 5.226

6.  Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles.

Authors:  Homayoun Shams; Peter Klucar; Steven E Weis; Ajit Lalvani; Patrick K Moonan; Hassan Safi; Benjamin Wizel; Katie Ewer; Gerald T Nepom; David M Lewinsohn; Peter Andersen; Peter F Barnes
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

Authors:  Alexander S Pym; Priscille Brodin; Laleh Majlessi; Roland Brosch; Caroline Demangel; Ann Williams; Karen E Griffiths; Gilles Marchal; Claude Leclerc; Stewart T Cole
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

8.  Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection.

Authors:  Inger Brock; Karin Weldingh; Eliane M S Leyten; Sandra M Arend; Pernille Ravn; Peter Andersen
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 9.  Dynamics of cytokine generation in patients with active pulmonary tuberculosis.

Authors:  Eun-Kyeong Jo; Jeong-Kyu Park; Hazel M Dockrell
Journal:  Curr Opin Infect Dis       Date:  2003-06       Impact factor: 4.915

10.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.

Authors:  Dirk Schnappinger; Sabine Ehrt; Martin I Voskuil; Yang Liu; Joseph A Mangan; Irene M Monahan; Gregory Dolganov; Brad Efron; Philip D Butcher; Carl Nathan; Gary K Schoolnik
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

View more
  15 in total

1.  Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population.

Authors:  Vinod B Patel; Ravesh Singh; Cathy Connolly; Yacoob Coovadia; Abdool K C Peer; Priyashini Parag; Victoria Kasprowicz; Alimuddin Zumla; Thumbi Ndung'u; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

2.  Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.

Authors:  K Schepers; F Mouchet; V Dirix; I De Schutter; K Jotzo; V Verscheure; P Geurts; M Singh; J P Van Vooren; F Mascart
Journal:  Clin Vaccine Immunol       Date:  2013-10-23

Review 3.  Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery.

Authors:  Shajo Kunnath-Velayudhan; Maria Laura Gennaro
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states.

Authors:  Urban Sester; Mathias Fousse; Jan Dirks; Ulrich Mack; Antje Prasse; Mahavir Singh; Ajit Lalvani; Martina Sester
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

5.  Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis.

Authors:  Rosalyn Casey; Deena Blumenkrantz; Kerry Millington; Damien Montamat-Sicotte; Onn Min Kon; Melissa Wickremasinghe; Samuel Bremang; Murphy Magtoto; Saranya Sridhar; David Connell; Ajit Lalvani
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

6.  Immune responses to the enduring hypoxic response antigen Rv0188 are preferentially detected in Mycobacterium bovis infected cattle with low pathology.

Authors:  Gareth J Jones; Chris Pirson; Hannah P Gideon; Katalin A Wilkinson; David R Sherman; Robert J Wilkinson; R Glyn Hewinson; H Martin Vordermeier
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

7.  The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident.

Authors:  Louise Bradshaw; Elizabeth Davies; Michael Devine; Peter Flanagan; Paul Kelly; Kevin O'Connor; Francis Drobniewski; Vladislav Nikolayevskyy; Ibrahim Abubakar
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

8.  How should I interpret an interferon gamma release assay result for tuberculosis infection?

Authors:  Ibrahim Abubakar; Helen Ruth Stagg; Hilary Whitworth; Ajit Lalvani
Journal:  Thorax       Date:  2013-03       Impact factor: 9.139

9.  High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study.

Authors:  Timothy S C Hinks; Nimu Varsani; David T Godsiff; Thomas C Bull; Katherine L Nash; Lisa McLuckie; Catherine Maule; Tessa Flower; Anthony Warley
Journal:  BMC Infect Dis       Date:  2012-12-06       Impact factor: 3.090

Review 10.  Targeting immunometabolism in host defence against Mycobacterium tuberculosis.

Authors:  Frederick J Sheedy; Maziar Divangahi
Journal:  Immunology       Date:  2020-10-28       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.